Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Methylphenidate 2Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Asthenia × Methylphenidate × Clear all
NCT01773837 2017-05-09

Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients

Clinica Universidad de Navarra, Universidad de Navarra

Phase 3 Terminated
100 enrolled

Asthenia

NCT00273741 2009-12-07

Ritaline

University Hospital, Grenoble

Phase 3 Terminated
39 enrolled

Asthenia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡